Premenstrual syndrome and exercises

Phase 4

• Conditions: Premenstrual syndrome

• Registration Number: PACTR201908589835132
• Lead Sponsor: Faculty of Physical Therapy

Brief Summary

Results revealed that the resistive group showed a highly significant decrease in premenstrual symptoms score (p=0.0001), progesterone (p=0.0001), prolactin (p=0.0001) and significant decrease in estradiol (p=0.004) post treatment. While WBV group showed a highly significant decrease in premenstrual symptoms score (p=0.0001), prolactin (p=0.001)and a significant decrease in estradiol (p=.042), progesterone (p=0.039) post-treatment. However, resistive group showed a highly significant decrease in premenstrual symptoms score (p=0.0019) and a significant decrease in estradiol (p=0.0027), progesterone (p=0.046) and prolactin (p=0.042) when compared to WBV group.

Detailed Description

Not available

Study Timeline

• Results First Posted: 2015-08-23
• Study Start: 2019-06-26
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Participants ages ranged from 16-20 years and their body mass index was <19.9kg/m2.
They experienced regular menstrual cycles.
They were diagnosed with PMS according to PMS questionnaire.

Exclusion Criteria

Females with the following criteria were excluded including a history of pelvic pathology, pelvic inflammatory diseases, endometriosis, cardiac diseases, thyroid diseases, taking oral contraceptive pills, or smoking.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estradiol ;Progesterone;Prolactin

Secondary Outcome Measures

Name	Time	Method
Premenstrual symptoms including anxiety, depression, hyper hydration, craving and other symptoms, cramp and low back pain